Claire Laporte

Partner - Boston

Claire Laporte
Download Media Photo

Contact Information


617.832.7017 Download vCard

Claire Laporte is an experienced trial lawyer who has received recognition in both Chambers USA and Massachusetts SuperLawyers for her intellectual property practice. She represents clients in complex patent litigation and technology-related matters in a broad range of technical specialties including biotechnology, medical devices, pharmaceuticals, e-commerce, computer vision, and other software.

More »


  • Harvard Law School, J.D., cum laude, 1989
  • Princeton University Woodrow Wilson School of International and Public Affairs, A.B., summa cum laude, 1982
  • Clerkship: Justice Ruth I. Abrams, Supreme Judicial Court of Massachusetts, 1989-90

Representative Experience

  • Represented GI Dynamics in patent ownership and inventorship litigation brought by W.L. Gore & Associates, Inc., the makers of Gore-Tex®. The case pertained to Gore’s claim of co-ownership in the patent portfolio of our client, GI Dynamics. Gore dropped its claims shortly before trial, leaving our client in exclusive control over the patent portfolio Gore had sought to co-own.
  • Wrote amicus brief in the U.S. Supreme Court on behalf of amicus Federal Circuit Bar Association in Association for Molecular Pathology v. U.S. Patent and Trademark Office (“Myriad”), concerning the patentability of isolated human genetic material and methods for using such material.
  • Admitted pro hac vice on behalf of the Dana-Farber Cancer Institute in five related Patent Office interference proceedings relating to human PD-L1.
  • Won a ruling on behalf of Chinese lysine producer Global Bio-Chem Technology Group Company Limited, first in the International Trade Commission and then in the Federal Circuit, that two biotechnology patents owned by multibillion-dollar chemical company Ajinomoto Co. were invalid and that Ajinomoto had committed inequitable conduct.
  • Obtained a rare writ of mandamus from the Federal Circuit ordering the Eastern District of Texas to transfer a patent litigation to the Northern District of California.
  • Won a claim construction ruling for Biogen Idec in a case concerning viral enhancers. The district court granted summary judgment against Sanofi Aventis and in favor of Biogen Idec and its co-defendant, Genentech, based on the claim construction. The Federal Circuit recently affirmed the claim construction and summary judgment rulings.
  • Won a jury verdict of willful infringement in a medical device patent infringement trial for C.R. Bard against U.S. Surgical Corporation.
  • Represented Biogen Idec, Genzyme and Baxter Healthcare in multidistrict litigation against Columbia University challenging patent on recombinant DNA technology, resulting in Columbia’s granting plaintiffs a royalty-free covenant not to sue.
  • Represented in e-commerce patent infringement litigation; case settled after favorable claim construction ruling.
  • Represented Electro Scientific Industries in patent infringement litigation concerning computer vision systems for chip placement; case settled after favorable Markman finding.
  • Obtained covenant not to sue in SVG Lithography, Inc. v. Ultratech Stepper, Inc.

Foley Hoag Alerts & Updates


  • Listed in MASSACHUSETTS SUPER LAWYERS (2004, 2006-2012)
  • Ranked by CHAMBERS USA: AMERICA’S LEADING LAWYERS FOR BUSINESS as one of Massachusetts’ leading intellectual property lawyers (2006-2017)


  • Federal Circuit Bar Association, former Board member; currently member of Amicus Committee
  • Boston Patent Law Association, Co-Chair of Medical Devices Committee 
  • Board member, Lawyers’ Committee for Civil Rights Under Law of the Boston Bar Association
  • Boston Bar Association, Member
  • AIPLA, Member
  • Board Member, Cambridge Health Alliance Foundation
  • Board of Overseers, The Handel & Haydn Society
  • Panelist for discussion on “Perspectives on Mooting,” Spring Meeting of American Academy of Appellate Lawyers, April 2017
  • Panelist, "Intellectual Property Law in 2017," New England Corporate Counsel Association, Inc., February 2017
  • Presentation on “Health IP Update” at “Health Law Year in P/Review,” sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, January 2017
  • Webinar for American Law Institute on “The Defend Trade Secrets Act of 2016:  What You Need to Know,” June 2016
  • Panelist for presentation on “The Defend Trade Secrets Act of 2016: A Federal Private Action for Global Unfair Competition,” Boston Bar Association, May 2016
  • Presentation on “Health IP Update” at “Health Law Year in P/Review,” sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, January 2016
  • Presentation on “Life Sciences IP: Important Cases of 2014 and a Preview for 2015” at “Health Law Year in P/Review,” sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, January 2015
  • Presentation on “Developments in Patent Law and Policy” at workshop sponsored by the National Bureau of Economic Research at the Massachusetts Institute of Technology, November 2014
  • Presentation on “New Developments in the Law of Obviousness,” meeting of the Connecticut Intellectual Property Association, November 2014
  • Presentation on “Emerging Issues in PTAB Proceedings: New Developments in the Law of Obviousness” at Boston Patent Law Association seminar “The TTAB & PTAB Come to Boston,” Northeastern University School of Law, October 2014
  • Organization of and presentation at “Setting Sail in Uncharted Waters: The Life Science Industry Prepares for Post-Grant Review,” September 2014
  • Presentation on “Personalized Medicine and Diagnostics: New Barriers to Patent Enforcement,” at Workshop on Personalized Medicine and Intellectual Property, Boston University, August 2014
  • Presentation on "Claim Construction in Biotechnology Cases: Developments and Pitfalls," meeting of the American Bar Association/Boston Bar Association, May 2014
  • Invited lecture at the Meeting on The Biology of Genomes held at Cold Spring Harbor Laboratory, "The Court Has Spoken - What Did It Say? Implications of Recent U.S. Supreme Court Decisions on Diagnostic Testing and Gene Patenting," May 2014
  • Presentation on recent life sciences IP cases and implications for the industry at “Health Law Year in P/Review,” sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, January 2014
  • Panel discussion at Harvard Law School on Supreme Court’s ruling in the Myriad case concerning gene patents (starting at 29:28), September 2013
  • Live television broadcast on program “That’s the Law!” discussing gene patents, April 2013
  • Live radio broadcast discussion on DOMA, NightSide with Dan Rea, CBS Boston News Radio, April 2013
  • Moderated "Town Hall" panels at Federal Circuit Bar Association Bench/Bar Conference, June 2011
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts

Court Admissions

  • U.S. District Court for the District of Massachusetts
  • U.S. District Court for the Western District of Michigan
  • U.S. District Court for the Eastern District of Texas
  • U.S. Court of Appeals Federal Circuit
  • U.S. Court of Appeals Ninth Circuit
  • U.S. Court of Appeals First Circuit
  • Supreme Court of the United States